Mira Pharmaceuticals, Common Stock Price on December 13, 2024
MIRA Stock | 1.12 0.03 2.61% |
If you're considering investing in MIRA Stock, it is important to understand the factors that can impact its price. As of today, the current price of MIRA Pharmaceuticals, stands at 1.12, as last reported on the 14th of December 2024, with the highest price reaching 1.15 and the lowest price hitting 1.07 during the day. At this point, MIRA Pharmaceuticals, is risky. MIRA Pharmaceuticals, has Sharpe Ratio of 0.0028, which conveys that the firm had a 0.0028% return per unit of volatility over the last 3 months. We have found twenty-three technical indicators for MIRA Pharmaceuticals,, which you can use to evaluate the volatility of the firm. Please verify MIRA Pharmaceuticals,'s mean deviation of 4.69, and Risk Adjusted Performance of (0) to check out if the risk estimate we provide is consistent with the expected return of 0.0196%.
At present, MIRA Pharmaceuticals,'s Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 26.9 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 17.3 M. . At present, MIRA Pharmaceuticals,'s Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 4.68, whereas Price Earnings Ratio is forecasted to decline to (1.71). MIRA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
MIRA |
Sharpe Ratio = 0.0028
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | MIRA |
Estimated Market Risk
6.99 actual daily | 62 62% of assets are less volatile |
Expected Return
0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MIRA Pharmaceuticals, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MIRA Pharmaceuticals, by adding MIRA Pharmaceuticals, to a well-diversified portfolio.
Price Book 5.1901 | Book Value 0.296 | Enterprise Value 15.5 M | Enterprise Value Ebitda (1.45) | Shares Float 10 M |
Related Headline
Teva Pharma Headline on 13th of December 2024
Why Are Amicus, Immunocore, Immuneering Stocks Trading Lower... by finance.yahoo.com
Morgan Stanley downgraded Amicus Therapeutics Inc . Over the last year, the company has executed well commercially, met its goals financially by achieving nonGAAP profitability for 2024, and settled its Galafold patent litigation with Teva Pharmaceutical Industries Ltd. The analyst notes that Amicus is well-positioned, but expectations have increased with the companys progress, which are now largely priced into shares. The analyst downgraded the stock to Equal-weight from Overweigh
MIRA Pharmaceuticals, Valuation on December 13, 2024
It is possible to determine the worth of MIRA Pharmaceuticals, on a given historical date. On December 13, 2024 MIRA was worth 1.13 at the beginning of the trading date compared to the closed value of 1.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MIRA Pharmaceuticals, stock. Still, in general, we apply an absolute valuation method to find MIRA Pharmaceuticals,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MIRA Pharmaceuticals, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MIRA Pharmaceuticals,'s related companies.
Open | High | Low | Close | Volume | |
1.13 | 1.15 | 1.07 | 1.12 | 303,197 | |
12/14/2024 | 1.13 | 1.15 | 1.07 | 1.12 | 0.00 |
Backtest MIRA Pharmaceuticals, | | | MIRA Pharmaceuticals, History | | | MIRA Pharmaceuticals, Valuation | Previous |
MIRA Pharmaceuticals, Trading Date Momentum on December 13, 2024
On December 14 2024 MIRA Pharmaceuticals, Common was traded for 1.12 at the closing time. The top price for the day was 1.15 and the lowest listed price was 1.07 . There was no trading activity during the period 0.0. Lack of trading volume on December 14, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.89% . |
MIRA Pharmaceuticals, Fundamentals Correlations and Trends
By evaluating MIRA Pharmaceuticals,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MIRA Pharmaceuticals,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MIRA financial account trend analysis is a perfect complement when working with valuation or volatility modules.About MIRA Pharmaceuticals, Stock history
MIRA Pharmaceuticals, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MIRA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MIRA Pharmaceuticals, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MIRA Pharmaceuticals, stock prices may prove useful in developing a viable investing in MIRA Pharmaceuticals,
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 18.6 M | 17.3 M | |
Net Loss | -6.4 M | -6 M |
MIRA Pharmaceuticals, Stock Technical Analysis
MIRA Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
MIRA Pharmaceuticals, Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
MIRA Pharmaceuticals, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
MIRA Pharmaceuticals, December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how MIRA Pharmaceuticals, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MIRA Pharmaceuticals, shares will generate the highest return on investment. By undertsting and applying MIRA Pharmaceuticals, stock market strength indicators, traders can identify MIRA Pharmaceuticals, Common entry and exit signals to maximize returns
MIRA Pharmaceuticals, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MIRA Pharmaceuticals,'s price direction in advance. Along with the technical and fundamental analysis of MIRA Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MIRA to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | 0.0304 | |||
Total Risk Alpha | (1.00) | |||
Treynor Ratio | 0.0734 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for MIRA Stock analysis
When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |